AMPLIFY: efficacy of aclidinium vs tiotropium in COPD

Conclusions: In pts with COPD, AB was non-inferior to TIO in improving trough FEV1 and had similar efficacy for other bronchodilation and QoL outcomes at Wk 24.

Source: European Respiratory Journal - November 19, 2018 Category: Respiratory Medicine Authors: Sethi, S., Kerwin, E., Watz, H., Ferguson, G. T., Mroz, R., Segarra, R., Molins, E., Jarreta, D., Garcia-Gil, E. Tags: Airway pharmacology and treatment Source Type: research